Literature DB >> 507510

Experimental chemotherapy of histoplasmosis in nude mice.

D M Williams, J R Graybill, D J Drutz.   

Abstract

Nude (nu/nu) mice were infected with Histoplasma capsulatum and treated with varying doses of 3 drug regimens: oral ambruticin, intraperitoneal amphotericin B, and amphotericin B plus oral rifampin. Therapy with amphotericin B alone was the most effective regimen. High-dose ambruticin (50 mg/kg of body weight every 8 hours) led to significantly prolonged survival compared to that of untreated control animals, but no long-term cures. Addition of rifampin produced no benefit and might actually have decreased the efficacy of amphotericin B; this combination may be deleterious in a setting of immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 507510     DOI: 10.1164/arrd.1979.120.4.837

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

1.  Efficacy of nikkomycin Z in the treatment of murine histoplasmosis.

Authors:  J R Graybill; L K Najvar; R Bocanegra; R F Hector; M F Luther
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

2.  RNA interference-mediated silencing of the YPS3 gene of Histoplasma capsulatum reveals virulence defects.

Authors:  Megan L Bohse; Jon P Woods
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

3.  KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis.

Authors:  J R Graybill; L K Najvar; A Fothergill; T Hardin; M Rinaldi; C Lambros; S L Regen
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

4.  Treatment of histoplasmosis with MK-991 (L-743,872).

Authors:  J R Graybill; L K Najvar; E M Montalbo; F J Barchiesi; M F Luther; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

5.  Efficacy of ambruticin analogs in a murine model of coccidioidomycosis.

Authors:  Lisa F Shubitz; John N Galgiani; Zong-Qiang Tian; Ziyang Zhong; Pieter Timmermans; Leonard Katz
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.